New Key Statistics Module, Z-Score and F-Score
WBO:MRSA Key Ratios
Market Cap € M | 23,469.26 |
Enterprise Value € M | 20,519.36 |
P/E(ttm) | 15.76 |
PE Ratio without NRI | 18.08 |
Forward PE Ratio | 20.20 |
Price/Book | 0.50 |
Price/Sales | 0.55 |
Price/Free Cash Flow | 14.96 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.81 |
Revenue (TTM) € M | 45,485.00 |
EPS (TTM) € | 96.53 |
Beneish M-Score | -0.83 |
10-y EBITDA Growth Rate % | 12.90 |
5-y EBITDA Growth Rate % | 45.30 |
y-y EBITDA Growth Rate % | -409.40 |
EV-to-EBIT | -1.22 |
EV-to-EBITDA | -1.22 |
PEG | 0.40 |
Shares Outstanding M | 15.77 |
Net Margin (%) | 3.50 |
Operating Margin % | -41.28 |
Pre-tax Margin (%) | 4.43 |
Quick Ratio | 2.30 |
Current Ratio | 2.43 |
ROA % (ttm) | 2.06 |
ROE % (ttm) | 3.17 |
ROIC % (ttm) | -24.50 |
Dividend Yield % | 4.71 |
Altman Z-Score | 2.37 |
WBO:MRSA Number of Guru Trades
WBO:MRSA Volume of Guru Trades
Gurus Latest Trades with WBO:MRSA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
WBO:MRSA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data